- Home
- SVRA vs FRPH Comparison
SVRA vs FRPH Comparison
Compare SVRA & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRA | FRPH |
|---|---|---|
| Founded | 2007 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 435.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SVRA | FRPH |
|---|---|---|
| Price | $6.09 | $22.34 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $7.11 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 84.0K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $33,049,999.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $94.02 |
| Revenue Growth | N/A | ★ 5.21 |
| 52 Week Low | $1.89 | $21.68 |
| 52 Week High | $7.01 | $31.99 |
Technical Indicators
Market Signals| Indicator | SVRA | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 57.26 | 38.23 |
| Support Level | $5.92 | $22.70 |
| Resistance Level | $7.01 | $23.70 |
| Average True Range (ATR) | 0.40 | 0.56 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 37.33 | 6.51 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).